Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 2
2016 2
2018 6
2019 1
2020 2
2021 5
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N. Yanai H, et al. Among authors: hirsch a. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):49-59. doi: 10.1016/S2468-1253(21)00299-5. Epub 2021 Nov 2. Lancet Gastroenterol Hepatol. 2022. PMID: 34739863 Clinical Trial.
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Ben-Horin S, Salomon N, Karampekos G, Viazis N, Lahat A, Ungar B, Eliakim R, Kuperstein R, Kriger-Sharabi O, Reiss-Mintz H, Yanai H, Dotan I, Zittan E, Maharshak N, Hirsch A, Weitman M, Mantzaris GJ, Kopylov U. Ben-Horin S, et al. Among authors: hirsch a. Clin Gastroenterol Hepatol. 2024 Feb;22(2):347-356.e6. doi: 10.1016/j.cgh.2023.05.023. Epub 2023 Jun 9. Clin Gastroenterol Hepatol. 2024. PMID: 37302449 Clinical Trial.
Vedolizumab in the treatment of Crohn's disease.
Tarabar D, Hirsch A, Rubin DT. Tarabar D, et al. Among authors: hirsch a. Expert Rev Gastroenterol Hepatol. 2016;10(3):283-90. doi: 10.1586/17474124.2016.1135051. Epub 2016 Jan 25. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26810276 Review.
Enteric infections complicating ulcerative colitis.
Micic D, Hirsch A, Setia N, Rubin DT. Micic D, et al. Among authors: hirsch a. Intest Res. 2018 Jul;16(3):489-493. doi: 10.5217/ir.2018.16.3.489. Epub 2018 Jul 27. Intest Res. 2018. PMID: 30090049 Free PMC article.
Risk Factors for Malnutrition among IBD Patients.
Einav L, Hirsch A, Ron Y, Cohen NA, Lahav S, Kornblum J, Anbar R, Maharshak N, Fliss-Isakov N. Einav L, et al. Among authors: hirsch a. Nutrients. 2021 Nov 16;13(11):4098. doi: 10.3390/nu13114098. Nutrients. 2021. PMID: 34836353 Free PMC article.
Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study.
Yanai H, Salomon N, Lahat A, Ungar B, Eliakim R, Kriger-Sharabi O, Reiss-Mintz H, Koslowsky B, Shitrit AB, Tamir-Degabli N, Dotan I, Zittan E, Maharshak N, Hirsch A, Ben-Horin S, Kopylov U. Yanai H, et al. Among authors: hirsch a. Aliment Pharmacol Ther. 2023 Jul;58(2):175-181. doi: 10.1111/apt.17538. Epub 2023 May 8. Aliment Pharmacol Ther. 2023. PMID: 37157131
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.
Lichtenstein L, Koslowsky B, Ben Ya'acov A, Avni-Biron I, Ovadia B, Ben-Bassat O, Naftali T, Kopylov U, Haberman Y, Eran HB, Eliakim R, Lahat-Zok A, Hirsch A, Zittan E, Maharshak N, Waterman M, Israeli E, Goren I, Ollech JE, Yanai H, Ungar B, Avidan B, Ben Hur D, Melamud B, Segol O, Shalem Z, Dotan I, Odes SH, Ben-Horin S, Snir Y, Milgrom Y, Broide E, Goldin E, Delgado S, Ron Y, Cohen NA, Maoz E, Zborovsky M, Odeh S, Abu Freha N, Shachar E, Chowers Y, Engel T, Reiss-Mintz H, Segal A, Zinger A, Bar-Gil Shitrit A. Lichtenstein L, et al. Among authors: hirsch a. Vaccines (Basel). 2022 Feb 28;10(3):376. doi: 10.3390/vaccines10030376. Vaccines (Basel). 2022. PMID: 35335008 Free PMC article.
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
Harnik S, Abitbol CM, Haj Natour O, Yavzori M, Fudim E, Picard O, Naftali T, Broide E, Hirsch A, Selinger L, Shachar E, Yablecovitch D, Albshesh A, Coscas D, Kopylov U, Eliakim R, Ben-Horin S, Ungar B. Harnik S, et al. Among authors: hirsch a. J Crohns Colitis. 2024 Mar 1;18(3):341-348. doi: 10.1093/ecco-jcc/jjad156. J Crohns Colitis. 2024. PMID: 37691574
Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.
Ostromohov G, Fibelman M, Hirsch A, Ron Y, Cohen NA, Kariv R, Deutsch L, Kornblum J, Anbar R, Maharshak N, Fliss-Isakov N. Ostromohov G, et al. Among authors: hirsch a. United European Gastroenterol J. 2022 Feb;10(1):104-114. doi: 10.1002/ueg2.12182. Epub 2021 Dec 23. United European Gastroenterol J. 2022. PMID: 34939350 Free PMC article.
28 results